| # | Drug | Count |
|---|---|---|
| 0 | QUETIAPINE | 33 |
| 1 | METFORMIN | 28 |
| 2 | LAMOTRIGINE | 26 |
| 3 | LAMOTIRIGINE | 23 |
| 4 | LAMOTRIGINE CHEWABLE DISPERSIBLE | 23 |
| 5 | LAMOTRIGINE EXTENDED-RELEASE | 23 |
| 6 | METFORMIN ER 500 MG | 22 |
| 7 | METFORMIN ER 750 MG | 22 |
| 8 | BUPROPION | 21 |
| 9 | HYDROXYZINE | 21 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TRIPROLIDINE HCL, DEXTROMETHORPHAN HBR | 1 | 0.0556 |
| 1 | OMEPRAZOLE 20 MG | 1 | 0.0049 |
| 2 | EPINEPHRINE HYDROCHLORIDE | 2 | 0.0042 |
| 3 | MINERAL OIL, WHITE PETROLATUM | 1 | 0.0035 |
| 4 | PRAZOSIN | 16 | 0.0026 |
| 5 | ECONAZOLE NITRATE | 2 | 0.0021 |
| 6 | PIMOZIDE | 1 | 0.0021 |
| 7 | MIGLUSTAT | 2 | 0.0017 |
| 8 | ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE | 1 | 0.0017 |
| 9 | PRAZOSIN HYDROCHLORIDE | 2 | 0.0014 |
| # | Drug class | Count |
|---|---|---|
| 0 | Atypical Antipsychotic [EPC] | 50 |
| 1 | Benzodiazepine [EPC] | 48 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 47 |
| 3 | Mood Stabilizer [EPC] | 36 |
| 4 | Anti-epileptic Agent [EPC] | 34 |
| 5 | Corticosteroid [EPC] | 23 |
| 6 | Catecholamine [EPC] | 18 |
| 7 | alpha-Adrenergic Agonist [EPC] | 17 |
| 8 | beta-Adrenergic Agonist [EPC] | 17 |
| 9 | Acetylcholine Release Inhibitor [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 2 | 0.0029 |
| 1 | Enzyme Stabilizer [EPC] | 2 | 0.0017 |
| 2 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 2 | 0.0016 |
| 3 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 4 | Lymphocyte Growth Factor [EPC] | 1 | 0.0008 |
| 5 | Glucosylceramide Synthase Inhibitor [EPC] | 2 | 0.0007 |
| 6 | Lymphocyte Function-Associated Antigen-1 Antagonist [EPC] | 8 | 0.0005 |
| 7 | Recombinant Human Nerve Growth Factor [EPC] | 6 | 0.0004 |
| 8 | Neuraminidase Inhibitor [EPC] | 1 | 0.0004 |
| 9 | Serotonin and Norepinephrine Reuptake Inhibitor [EPC] | 1 | 0.0003 |